Latest / Oncology Data Advisor
Harnessing Precision Medicine in Oncology With Ofer Sharon, MD
In this interview, Ofer Sharon, MD, the CEO of OncoHost, explains the unique opportunities for harnessing precision medicine in oncology, the unmet needs regarding biomarker development, and the potential of utilizing a multicomponent biomarker approach for understanding the mechanisms of therapy resistance and developing novel pathways for treatment.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.